A 35-year-old woman from Kerala with a known diagnosis of beta-thalassemia intermedia presents with sudden-onset dyspnea, chest pain, and syncope. Her hemoglobin is 8.5 g/dL (baseline ~8 g/dL), and D-dimer is markedly elevated. CT pulmonary angiography confirms pulmonary thromboembolism. Which of the following mechanisms BEST explains the hypercoagulable state in this patient?

Explanation

## Thromboembolism in Thalassemia: Pathophysiology ### Clinical Context **Key Point:** Patients with thalassemia intermedia and major have a significantly elevated risk of **thromboembolism** (venous and arterial), which is a major cause of morbidity and mortality. This patient's presentation with PE is a classic complication. ### Mechanisms of Hypercoagulability in Thalassemia | Mechanism | Pathophysiology | Evidence | |-----------|-----------------|----------| | **Endothelial damage & TF expression** | Chronic hemolysis → ROS, lipid peroxidation, NO depletion → endothelial injury → ↑ tissue factor (TF) | Primary driver; TF is the main initiator of coagulation | | Platelet activation | Phosphatidylserine exposure on RBC membrane; microparticles | Contributes but not primary | | Reduced anticoagulants | Protein C/S loss in cirrhosis; antithrombin depletion | Secondary, not the main mechanism | | Factor X release | Not a recognized mechanism in thalassemia pathophysiology | Incorrect | ### Correct Mechanism: Tissue Factor Upregulation **High-Yield:** Chronic hemolysis in thalassemia causes: 1. **Oxidative stress** → generation of reactive oxygen species (ROS) 2. **Endothelial dysfunction** → reduced nitric oxide (NO) bioavailability 3. **Tissue factor (TF) expression** on endothelial cells and monocytes 4. **Thrombin generation** → venous and arterial thrombosis **Clinical Pearl:** Elevated **D-dimer** and **thrombin-antithrombin (TAT) complexes** are markers of ongoing thrombin generation in thalassemia patients. Tissue factor is the primary driver of this hypercoagulable state. ### Why Thalassemia Intermedia is High-Risk - Chronic hemolysis with splenectomy (if performed) → further ↑ thrombotic risk - Iron overload → oxidative stress and endothelial damage - Abnormal RBC membrane → microparticle release **Mnemonic: THROMBOSIS in Thalassemia — TF (Tissue Factor) + Hemolysis + ROS + Oxidative stress + Microparticles + BOS (Blood stasis) + Splenectomy + Increased viscosity + Stasis** ### Clinical Management - **Anticoagulation:** Consider prophylactic anticoagulation in high-risk patients (splenectomized, previous thrombosis) - **Antioxidants:** Vitamin E, folic acid supplementation - **Iron chelation:** Reduces oxidative stress [cite:Robbins 10e Ch 13; Harrison 21e Ch 109]